Galectin-3 expression and subcellular localization in senescent human fibroblasts

Experimental Cell Research

Volumn 255, Issue 2, 2000, Pages 278-290

  Openo, Kyle P ^a   Kadrofske, Mark M ^a   Patterson, Ronald J ^b   Wang, John L ^a  

^a Michigan State University   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 3; LEPTOMYCIN B; LEUCINE; MESSENGER RNA PRECURSOR;

ARTICLE; CELL AGING; CELL PROLIFERATION; CELLULAR DISTRIBUTION; ENZYME LOCALIZATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SPLICING; SENESCENCE; STRAIN DIFFERENCE;

EID: 0034653518     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4782     Document Type: Article

References (42)

1. Hayflick L. The limited in vitro life span of human diploid cell strains. Exp. Cell Res. 37:1965;614-636.
2. Goldstein S. Replicative senescence: The human fibroblast comes of age. Science. 249:1990;1129-1133.
3. Martin G. M., Sprague C. A., Epstein C. J. Replicative life span of cultivated human cells: Effects of donor's age, tissue, and genotype. Lab. Invest. 23:1970;86-92.
4. Schneider E. L., Mitsui Y. The relationship between in vitro cellular aging and in vivo human age. Proc. Natl. Acad. Sci. USA. 73:1976;3584-3588.
5. Cristofalo V. J., Allen R. G., Pignolo R. J., Martin B. G., Beck J. C. Relationship between donor age and the replicative lifespan of human cells in culture: A reevaluation. Proc. Natl. Acad. Sci. USA. 95:1998;10614-10619.
6. Salk D. Werner's syndrome: A review of recent research with an analysis of connective tissue metabolism, growth control of cultured cells, and chromosomal aberrations. Hum. Genet. 62:1982;1-15.
7. Rohme D. Evidence for a relationship between longevity of mammalian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo. Proc. Natl. Acad. Sci. USA. 78:1981;5009-5013.
8. Gutsmann-Conrad A., Heydari A. R., You S., Richardson A. The expression of heat shock protein 70 decreases with cellular senescence in vitro and in cells derived from young and old human subjects. Exp. Cell Res. 241:1998;404-413.
9. Dimri G. P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E. E., Linskens M., Rubeli I., Pereira-Smith O., Peacocke M., Campisi J. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA. 92:1995;9363-9367.
10. Sinclair D. A., Mills K., Guarente L. Accelerated aging and nucleolar fragmentation in yeast sgs1 mutants. Science. 277:1997;1313-1316.
11. Patterson R. J., Dagher S. F., Vyakarnam A., Wang J. L. Nuclear galectins: Functionally redundant components in processing of pre-mRNA. Trends Glycosci. Glycotechnol. 9:1997;77-85.
12. Moutsatsos I. K., Wade M., Schindler M., Wang J. L. Endogenous lectins from cultured cells: Nuclear localization of carbohydrate-binding protein 35 in proliferating cells. Proc. Natl. Acad. Sci. USA. 84:1987;6452-6456.
13. Hamman K. K., Cowles E. A., Wang J. L., Anderson R. L. Expression of carbohydrate binding protein 35 in human fibroblasts: Variations in the levels of mRNA, protein, and isoelectric species as a function of replicative competence. Exp. Cell Res. 196:1991;82-91.
14. Morgan T. L., Yang D., Fry D. G., Hurlin P. J., Kohler S. K., Maher V. M., McCormick J. J. Characteristics of an infinite life span diploid human fibroblast cell strain and a near-diploid strain arising from a clone of cells expressing a transfected v-myc oncogene. Exp. Cell Res. 197:1991;125-136.
15. Steck P. A., Voss P. G., Wang J. L. Growth control in cultured 3T3 fibroblasts. Assays of cell proliferation and demonstration of a growth inhibitory activity. J. Cell Biol. 83:1979;562-575.
16. Vindelov L. L., Christensen I. J., Nissen N. I. Standardization of high-resolution flow cytometric DNA analysis by the simultaneous use of chicken and trout red blood cells as internal reference standards. Cytometry. 3:1983;328-331.
17. r mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. J. Immunol. 128:1982;1221-1228.
18. Agrwal N., Sun Q., Wang S.-Y., Wang J. L. Carbohydrate binding protein 35. I. Properties of the recombinant polypeptide and the individuality of the domains. J. Biol. Chem. 268:1993;14931-14939.
19. Metcalf T. N., Szabo L. J., Schubert K. R., Wang J. L. Immunochemical identification of an actin-like protein from soybean seedlings. Nature. 285:1980;171-172.
20. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London). 227:1970;680-685.
21. Stein G. H., Yanishevsky R. M. Entry into S phase is inhibited in two immortal cell lines fused to senescent human diploid cells. Exp. Cell Res. 120:1979;155-165.
22. Pereira-Smith O. M., Smith J. R. Phenotype of low proliferative potential is dominant in hybrids of normal human fibroblasts. Somatic Cell Genet. 8:1982;731-742.
23. Tsay Y.-G., Lin N. Y., Voss P. G., Patterson R. J., Wang J. L. Export of galectin-3 from nuclei of digitonin-permeabilized mouse 3T3 fibroblasts. Exp. Cell Res. 252:1999;250-261.
24. Nishi K., Yoshida M., Fujiwara D., Nishikawa M., Horinouchi S., Beppu T. Leptomycin B targets a regulatory cascade of crm1, a fission yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. J. Biol. Chem. 269:1994;6320-6324.
25. Fornerod M., Ohno M., Yoshida M., Mattaj I. W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell. 90:1997;1051-1060.
26. Ossareh-Nazari B., Bachelerie F., Dargemont C. Evidence for a role of CRM1 in signal-mediated nuclear protein export. Science. 278:1997;141-144.
27. Isaurralde E., Adam S. Transport of macromolecules between the nucleus and the cytoplasm. RNA. 4:1998;351-364.
28. Norwood T. H., Pendergrass W. R., Sprague C. A., Martin G. M. Dominance of the senescent phenotype in heterokaryons between replicative and post-replicative human fibroblast-like cells. Proc. Natl. Acad. Sci. USA. 71:1974;2231-2235.
29. Lotz M. M., Andrews C. W., Korzelius C. A., Lee E. C., Steele G. D., Clarke A., Mercurio A. M. Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc. Natl. Acad. Sci. USA. 90:1993;3466-3470.
30. Yu C. E., Oshima J., Fu Y. H., Wijsman E. M., Hisama F., Alisch R., Matthews S., Nakura J., Miki T., Ouais S., Martin G. M., Mulligan J., Schellenberg G. D. Positional cloning of the Werner's syndrome gene. Science. 272:1996;258-262.
31. Gray M. D., Shen J. C., Kamath-Loeb A. S., Blank A., Sopher B. L., Martin G. M., Oshima J., Loeb L. A. The Werner syndrome protein is a DNA helicase. Nat. Genet. 17:1997;100-103.
32. Gray M. D., Wang L., Youssoufian H., Martin G. M., Oshima J. Werner helicase is localized to transcriptionally active nucleoli of cycling cells. Exp. Cell Res. 242:1998;487-494.
33. Marciniak R. A., Lombard D. B., Johnson F. B., Guarente L. Nucleolar localization of the Werner syndrome protein in human cells. Proc. Natl. Acad. Sci. USA. 95:1998;6887-6892.
34. Shiratori M., Sakamoto S., Suzuki N., Tokutake Y., Kawabe Y., Enomoto T., Sugimoto M., Goto M., Matsumoto T., Furuichi Y. Detection by epitope-defined monoclonal antibodies of Werner DNA helicases in the nucleoplasm and their upregulation by cell transformation and immortalization. J. Cell Biol. 144:1999;1-9.
35. Matsumoto T., Shimamoto A., Goto M., Furuichi Y. Impaired nuclear localization of defective DNA helicases in Werner's syndrome. Nat. Genet. 16:1997;335-336.
36. Moll U. M., Riou G., Levine A. J. Two distinct mechanisms alter p53 in breast cancer: Mutation and nuclear exclusion. Proc. Natl. Acad. Sci. USA. 89:1992;7262-7266.
37. Laín S., Xirodimas D., Lane D. P. Accumulating active p53 in the nucleus by inhibition of nuclear export: A novel strategy to promote the p53 tumor suppressor function. Exp. Cell Res. 253:1999;315-324.
38. Taylor J., Lymboura M., Pace P. E., A'Hern R. P., Desai A. J., Shousha S., Coombes R. C., Ali S. An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int. J. Cancer. 79:1998;334-342.
39. Chen Y., Chen S.-F., Riley D. J., Allred D. C., Chen P.-L., Von Hoff D., Osborne C. K., Lee W.-H. Aberrant subcellular localization of BRCA1 in breast cancer. Science. 270:1995;789-791.
40. Agrwal N. Carbohydrate Binding Protein 35: In Vivo and In Vitro Expression Properties of the Polypeptide. 1992;Michigan State University, East Lansing.
41. Chang C.-D., Phillips P., Lipson K. E., Cristofalo V. J., Baserga R. Senescent human fibroblasts have a post-transcriptional block in the expression of the proliferating cell nuclear antigen gene. J. Biol. Chem. 266:1991;8663-8666.
42. Magnuson V. L., Young M., Schattenberg D. G., Mancini M. A., Chen D., Steffensen B., Klebe R. J. The alternative splicing of fibronectin pre-mRNA is altered during aging and in response to growth factors. J. Biol. Chem. 266:1991;14654-14662.